WELL Health Technologies (HAM:W7V) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HAM:W7V WELL Health Technologies Corp HAM:W7V
73 GF Score
Price €2.60
GF Value €4.57
! 5 Warning Signs
View Full Analysis

What is WELL Health Technologies Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

HAM:W7V
73GF Score
WELL Health Technologies Corp HAM:W7V
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is WELL Health Technologies (HAM:W7V) Overvalued in 2026?

Based on GuruFocus' analysis, WELL Health Technologies stock appears to be undervalued. The current stock price of €2.60 is trading 43.2% below its estimated GF Value™ of €4.57.

Key valuation signals for HAM:W7V:

  • Dividends Received:
  • GF Value™: €4.57 vs. price of €2.60 (43.2% below fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the HAM:W7V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

WELL Health Technologies Business Description

Address 375 Water Street, Suite 550, Vancouver, BC, CAN, V6B 5C6
WELL Health Technologies Corp is a Canadian digital healthcare company that owns and operates a network of primary and specialized healthcare clinics while supplying software and services to healthcare providers. Its operations span three main areas: Canadian patient services, including primary care and specialized clinics; U.S. patient services, which include primary care, telehealth, anesthesia and gastrointestinal services; and a SaaS and technology segment offering electronic medical records, patient engagement, eReferral, billing and practice management tools, cybersecurity, and AI-enabled clinical applications. The company serves physicians, clinics, hospitals and patients, generating revenue through clinical service fees, software subscriptions and technology licensing. Its primary market is Canada, with a substantial presence in the United States. WELL Health has grown largely through acquisitions of clinics and health technology businesses, and it continues to expand its digital health platform and AI-based offerings.
73GF Score

Get the complete analysis for HAM:W7V

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.60
Price
€4.57
GF Value